cannabis stocks

5 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Tilray's Revenue Gains Mask Deeper Problems: Why Skeptics Remain Unconvinced

Tilray posts record $217.5M quarterly revenue and narrows losses, but persistent negative cash flow and competitive headwinds keep investors wary.
TLRYrevenue growthcannabis stocks
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Altria's Cash Machine Outpaces Cannabis Volatility as Tilray Struggles

Altria's proven profitability and 6.1% dividend outshine Tilray's persistent losses and shareholder dilution in cannabis sector comparison.
TLRYMOshareholder dilutiondividend yield
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Aurora Cannabis Faces Headwinds Despite Cannabis Reclassification

Aurora Cannabis stock down 96% since 2021. Despite cannabis reclassification benefits, the company faces headwinds from weak revenue, losses, and exited U.S. operations.
ACBacquisition strategystock performance
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Tilray Faces Profitability Headwinds Despite Diversification Push

Tilray struggles with profitability despite diversification into hemp and beverages. Acquisition-driven growth caused shareholder dilution and asset write-downs, raising questions about long-term viability.
TLRYprofitability concernsacquisition strategy
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Tilray and Canopy Growth Navigate Evolving Cannabis Market Landscape

Tilray and Canopy Growth strengthen positions amid shifting U.S. cannabis regulations. Both improve financials, with Tilray offering broader geographic diversification versus Canopy's focused approach.
CGCTLRYCanopy Growthcannabis stocks